Learn More
Description
- The Recombinant Human MAGE 1 Protein is derived from E. coli
- Human malignant neoplasms carry rejection antigens that are recognized by the patients autologous, tumor directed and specific, cytolytic, CD8+T lymphocyte clones (CTL).
- An important group of antigens is coded by the MAGE family of genes.
- It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs).
- Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.
- This product is for research use only and is not approved for use in humans or in clinical diagnosis.
Specifications
Specifications
| Concentration | 0.1 mg/mL |
| For Use With (Application) | SDS-PAGE |
| Gene ID (Entrez) | 4100 |
| Molecular Weight (g/mol) | 38 kDa |
| Purification Method | >90%, by SDS-PAGE |
| Quantity | 5 μg |
| Source | E. coli |
| Storage Requirements | Store at -20 to -80°C. Avoid freeze-thaw cycles. |
| Gene Symbol | MAGEA1 |
| Buffer | Sterile filtered in 50 mM Tris-Acetate, pH 7.5, 1 mM EDTA and 20% glycerol |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
